CLOVER BIO-B (02197.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Oct15

Clover Biopharmaceuticals Announces Positive Preliminary Data for Two Clinical Trials

01:32

Aug26

CLOVER BIO-B released FY2025 Q1 earnings on August 26 (BJT), actual revenue HKD 1.742 M, actual EPS HKD -0.0428

15:00

CLOVER BIO-B released FY2025 Semi-Annual Earnings on August 26 During-Market (BJT), actual revenue HKD 3.523 M (forecast HKD 348.23 M), actual EPS HKD -0.087

08:00

CLOVER BIO-B released FY2025 Q2 earnings on August 26 During-Market BJT, actual revenue HKD 1.781 M, actual EPS HKD -0.044

08:00

Aug18

CLOVER BIO-B to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT), Forecast Revenue HKD 348.23 M

01:16

Jul17

Clover Biopharmaceuticals Completes First Cohort Enrollment in Respiratory Vaccine Phase I Clinical Trial

07:55

Schedules & Filings

Schedules

Filings

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.781 M, Net Income -55.42 M, EPS -0.044

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 25.81 M, Net Income -429.96 M, EPS -0.3424

Aug27

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue -5.426 M, Net Income -51.11 M, EPS -0.0408

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change